Zhang et al101 found that in TAC mice, metformin reduced cross‐sectional area of cardiomyocytes by about half and attenuated ventricular hypertrophy via activating AMPK/eNOS/NO pathway. This evidence concerns the gene PRKAA2 and cardiac hypertrophy.